344 related articles for article (PubMed ID: 16385511)
1. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
[TBL] [Abstract][Full Text] [Related]
2. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
3. Antigen induced arthritis (AIA) can be transferred by bone marrow transplantation: evidence that interleukin 6 is essential for induction of AIA.
Kobayashi H; Ohshima S; Nishioka K; Yamaguchi N; Umeshita-Sasai M; Ishii T; Mima T; Kishimoto T; Kawase I; Saeki Y
J Rheumatol; 2002 Jun; 29(6):1176-82. PubMed ID: 12064831
[TBL] [Abstract][Full Text] [Related]
4. Effect of a monoclonal antibody against interleukin-4 on suppression of antigen-induced arthritis in mice by oral administration of the inducing antigen.
Yoshino S; Yoshino J
Cell Immunol; 1998 Aug; 187(2):139-44. PubMed ID: 9732702
[TBL] [Abstract][Full Text] [Related]
5. Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis.
Egan PJ; van Nieuwenhuijze A; Campbell IK; Wicks IP
Arthritis Rheum; 2008 Dec; 58(12):3720-9. PubMed ID: 19035489
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of T-cell-mediated arthritis in mice by treatment with a monoclonal antibody against interleukin-4.
Yoshino S; Yoshino J
Cell Immunol; 1998 May; 185(2):153-7. PubMed ID: 9636693
[TBL] [Abstract][Full Text] [Related]
7. Reduction of arthritis severity in protease-activated receptor-deficient mice.
Yang YH; Hall P; Little CB; Fosang AJ; Milenkovski G; Santos L; Xue J; Tipping P; Morand EF
Arthritis Rheum; 2005 Apr; 52(4):1325-32. PubMed ID: 15818676
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH
Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879
[TBL] [Abstract][Full Text] [Related]
9. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
Kelchtermans H; Geboes L; Mitera T; Huskens D; Leclercq G; Matthys P
Ann Rheum Dis; 2009 May; 68(5):744-50. PubMed ID: 18480308
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis.
Lawlor KE; Campbell IK; O'Donnell K; Wu L; Wicks IP
Arthritis Rheum; 2001 Feb; 44(2):442-50. PubMed ID: 11229476
[TBL] [Abstract][Full Text] [Related]
11. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
[TBL] [Abstract][Full Text] [Related]
12. IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo.
Morita Y; Kitaura H; Yoshimatsu M; Fujimura Y; Kohara H; Eguchi T; Yoshida N
Calcif Tissue Int; 2010 Mar; 86(3):242-8. PubMed ID: 20111957
[TBL] [Abstract][Full Text] [Related]
13. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.
Hartgring SA; Willis CR; Alcorn D; Nelson LJ; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2010 Sep; 62(9):2716-25. PubMed ID: 20499386
[TBL] [Abstract][Full Text] [Related]
15. Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation.
Choi J; Ha KH; Byun MS; Min SY; Park MJ; Park HS; Oh HJ; Ju JH; Kim HY; Jue DM
Eur J Pharmacol; 2008 Oct; 595(1-3):108-13. PubMed ID: 18706406
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
18. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.
Miranda-Carús ME; Benito-Miguel M; Balsa A; Cobo-Ibáñez T; Pérez de Ayala C; Pascual-Salcedo D; Martín-Mola E
Arthritis Rheum; 2006 Apr; 54(4):1151-64. PubMed ID: 16575870
[TBL] [Abstract][Full Text] [Related]
20. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
